Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis, Necrotizing | 5 | 2020 | 80 | 2.020 |
Why?
|
| Intestines | 5 | 2019 | 416 | 1.290 |
Why?
|
| Short Bowel Syndrome | 5 | 2020 | 38 | 1.240 |
Why?
|
| Probiotics | 3 | 2019 | 88 | 0.750 |
Why?
|
| Infant, Premature, Diseases | 2 | 2018 | 77 | 0.740 |
Why?
|
| Monensin | 1 | 2019 | 16 | 0.660 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 36 | 0.650 |
Why?
|
| Appendectomy | 1 | 2019 | 37 | 0.640 |
Why?
|
| Lactobacillus | 1 | 2018 | 21 | 0.630 |
Why?
|
| Conversion to Open Surgery | 1 | 2018 | 11 | 0.630 |
Why?
|
| Intestinal Volvulus | 1 | 2018 | 10 | 0.620 |
Why?
|
| Appendicitis | 1 | 2019 | 64 | 0.620 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 97 | 0.620 |
Why?
|
| Protective Agents | 1 | 2018 | 33 | 0.610 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 117 | 0.600 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 149 | 0.590 |
Why?
|
| Intestinal Obstruction | 1 | 2018 | 89 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 788 | 0.560 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 461 | 0.540 |
Why?
|
| Trans-Activators | 1 | 2019 | 443 | 0.530 |
Why?
|
| Plant Extracts | 1 | 2018 | 245 | 0.520 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 510 | 0.480 |
Why?
|
| Laparoscopy | 2 | 2018 | 773 | 0.390 |
Why?
|
| Infant, Newborn | 6 | 2019 | 2486 | 0.370 |
Why?
|
| Cyclooxygenase 2 | 2 | 2020 | 99 | 0.330 |
Why?
|
| Animals, Newborn | 3 | 2019 | 524 | 0.320 |
Why?
|
| Postoperative Complications | 2 | 2018 | 2282 | 0.310 |
Why?
|
| Intussusception | 2 | 2017 | 18 | 0.300 |
Why?
|
| Infant | 6 | 2019 | 3161 | 0.290 |
Why?
|
| Child, Preschool | 6 | 2020 | 3733 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1237 | 0.280 |
Why?
|
| Length of Stay | 3 | 2019 | 736 | 0.280 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2019 | 113 | 0.270 |
Why?
|
| Infant, Premature | 2 | 2018 | 298 | 0.260 |
Why?
|
| Zebrafish | 5 | 2020 | 319 | 0.260 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1653 | 0.240 |
Why?
|
| Child | 6 | 2019 | 7175 | 0.210 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 2367 | 0.210 |
Why?
|
| Animals | 10 | 2020 | 27380 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2019 | 9058 | 0.190 |
Why?
|
| Enterocytes | 2 | 2019 | 18 | 0.180 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 51 | 0.180 |
Why?
|
| Rats | 4 | 2020 | 4041 | 0.180 |
Why?
|
| Peritonitis | 1 | 2020 | 29 | 0.180 |
Why?
|
| Adolescent | 5 | 2019 | 9267 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 122 | 0.170 |
Why?
|
| Time Factors | 2 | 2019 | 5339 | 0.170 |
Why?
|
| Fatty Liver | 1 | 2020 | 95 | 0.170 |
Why?
|
| Proton Ionophores | 1 | 2019 | 1 | 0.170 |
Why?
|
| Organoids | 1 | 2019 | 62 | 0.170 |
Why?
|
| Cerebrovascular Trauma | 1 | 2019 | 8 | 0.170 |
Why?
|
| Adaptation, Physiological | 2 | 2019 | 314 | 0.170 |
Why?
|
| Enterococcus faecalis | 1 | 2019 | 54 | 0.170 |
Why?
|
| Spleen | 1 | 2019 | 433 | 0.160 |
Why?
|
| Zonula Occludens Proteins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2018 | 3 | 0.160 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 805 | 0.160 |
Why?
|
| Infant Formula | 1 | 2018 | 17 | 0.150 |
Why?
|
| Drainage | 1 | 2019 | 162 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 88 | 0.150 |
Why?
|
| Intestine, Small | 2 | 2016 | 299 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 182 | 0.150 |
Why?
|
| Ileal Diseases | 1 | 2017 | 26 | 0.150 |
Why?
|
| Operative Time | 1 | 2018 | 143 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 114 | 0.150 |
Why?
|
| Humans | 13 | 2020 | 89367 | 0.150 |
Why?
|
| Inflammation | 2 | 2020 | 971 | 0.140 |
Why?
|
| Pylorus | 1 | 2017 | 14 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2018 | 102 | 0.140 |
Why?
|
| Burns, Chemical | 1 | 2017 | 12 | 0.140 |
Why?
|
| Esophageal Atresia | 1 | 2017 | 14 | 0.140 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Esophageal Stenosis | 1 | 2017 | 26 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2017 | 66 | 0.140 |
Why?
|
| Esophagus | 1 | 2017 | 106 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2019 | 727 | 0.130 |
Why?
|
| Stomach | 1 | 2017 | 111 | 0.130 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 38 | 0.130 |
Why?
|
| Esophagectomy | 1 | 2017 | 92 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1012 | 0.130 |
Why?
|
| Immune System | 1 | 2017 | 97 | 0.130 |
Why?
|
| Pyrroles | 1 | 2016 | 187 | 0.130 |
Why?
|
| Weight Loss | 1 | 2016 | 227 | 0.120 |
Why?
|
| Hospitalization | 2 | 2017 | 877 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2016 | 374 | 0.110 |
Why?
|
| Incidence | 1 | 2018 | 1596 | 0.110 |
Why?
|
| Gene Expression | 1 | 2017 | 1310 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2017 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2018 | 8245 | 0.080 |
Why?
|
| Male | 7 | 2019 | 42423 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 282 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5497 | 0.070 |
Why?
|
| Female | 6 | 2020 | 46222 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2662 | 0.070 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 12 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 27 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2020 | 33 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2020 | 64 | 0.050 |
Why?
|
| Epinephrine | 1 | 2020 | 88 | 0.050 |
Why?
|
| Alanine | 1 | 2020 | 83 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2020 | 70 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 65 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 172 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 71 | 0.040 |
Why?
|
| Erythrocyte Inclusions | 1 | 2019 | 1 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2020 | 273 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 106 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 196 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 261 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 302 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 428 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2019 | 254 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 280 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 69 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 345 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 684 | 0.040 |
Why?
|
| Enema | 1 | 2017 | 39 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 146 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2020 | 478 | 0.040 |
Why?
|
| Random Allocation | 1 | 2016 | 327 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 233 | 0.030 |
Why?
|
| Neck | 1 | 2017 | 104 | 0.030 |
Why?
|
| Mice | 2 | 2020 | 11764 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 2017 | 60 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 371 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2496 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2016 | 143 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 661 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 2001 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2016 | 146 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 233 | 0.030 |
Why?
|
| beta Catenin | 1 | 2016 | 266 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 253 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 321 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 1144 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 3219 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 521 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 2440 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1374 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1800 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 3018 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2014 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1432 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1767 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 3386 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 6316 | 0.010 |
Why?
|